SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-115586
Filing Date
2022-11-07
Accepted
2022-11-07 21:58:27
Documents
3
Period of Report
2022-10-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2229971-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2229971-1_3seq1.xml 3 6625
2 EXHIBIT 24 tm2229971d1_ex24.htm EX-24 10114
3 EXHIBIT 99 tm2229971d1_ex99.htm EX-99 1204
  Complete submission text file 0001104659-22-115586.txt   19387
Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55450 | Film No.: 221367024

Mailing Address 4880 HAVANA STREET SUITE 201 SOUTH DENVER CO 80239
Business Address 4880 HAVANA STREET SUITE 201 SOUTH DENVER CO 80239 303-371-0387
Medicine Man Technologies, Inc. (Issuer) CIK: 0001622879 (see all company filings)

IRS No.: 465289499 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8742 Services-Management Consulting Services